NO982816L - 17-sidekjedealkynyl- og 20-oksopregnaderivater av vitamin D, fremgangsmåte ved fremstilling derav og farmasöytiske sammensetninger derav - Google Patents
17-sidekjedealkynyl- og 20-oksopregnaderivater av vitamin D, fremgangsmåte ved fremstilling derav og farmasöytiske sammensetninger deravInfo
- Publication number
- NO982816L NO982816L NO982816A NO982816A NO982816L NO 982816 L NO982816 L NO 982816L NO 982816 A NO982816 A NO 982816A NO 982816 A NO982816 A NO 982816A NO 982816 L NO982816 L NO 982816L
- Authority
- NO
- Norway
- Prior art keywords
- derivatives
- oxo
- enrichment
- vitamin
- preparation
- Prior art date
Links
- 125000000304 alkynyl group Chemical group 0.000 title abstract 3
- 229930003316 Vitamin D Natural products 0.000 title 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 235000019166 vitamin D Nutrition 0.000 title 1
- 239000011710 vitamin D Substances 0.000 title 1
- 150000003710 vitamin D derivatives Chemical class 0.000 title 1
- 229940046008 vitamin d Drugs 0.000 title 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- XMDLIEZJERQGEY-ZHFUSYIKSA-N (1r,3s,5z)-5-[(2e)-2-[(1s,3as,7ar)-1-ethyl-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol Chemical class C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)CC)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C XMDLIEZJERQGEY-ZHFUSYIKSA-N 0.000 abstract 1
- 230000003509 anti-fertility effect Effects 0.000 abstract 1
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 230000000118 anti-neoplastic effect Effects 0.000 abstract 1
- 230000001028 anti-proliverative effect Effects 0.000 abstract 1
- 239000003418 antiprogestin Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 230000001506 immunosuppresive effect Effects 0.000 abstract 1
- 229940125721 immunosuppressive agent Drugs 0.000 abstract 1
- 239000003018 immunosuppressive agent Substances 0.000 abstract 1
- 230000003623 progesteronic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9526208.5A GB9526208D0 (en) | 1995-12-21 | 1995-12-21 | Chemical compounds |
| PCT/GB1996/003218 WO1997023453A1 (en) | 1995-12-21 | 1996-12-23 | 17-side chain alkynyl-and 20-oxopregna-derivatives of vitamin d, methods for their production and pharmaceutical compositions thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO982816D0 NO982816D0 (no) | 1998-06-18 |
| NO982816L true NO982816L (no) | 1998-08-21 |
Family
ID=10785847
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO982816A NO982816L (no) | 1995-12-21 | 1998-06-18 | 17-sidekjedealkynyl- og 20-oksopregnaderivater av vitamin D, fremgangsmåte ved fremstilling derav og farmasöytiske sammensetninger derav |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US6372926B2 (cs) |
| EP (1) | EP0874815B1 (cs) |
| JP (1) | JP2000503636A (cs) |
| KR (1) | KR19990076664A (cs) |
| CN (1) | CN1086694C (cs) |
| AT (1) | ATE200663T1 (cs) |
| AU (1) | AU710680B2 (cs) |
| CA (1) | CA2241011A1 (cs) |
| CZ (1) | CZ290930B6 (cs) |
| DE (1) | DE69612568T2 (cs) |
| DK (1) | DK0874815T3 (cs) |
| ES (1) | ES2155948T3 (cs) |
| GB (1) | GB9526208D0 (cs) |
| GR (1) | GR3036132T3 (cs) |
| HU (1) | HUP9903786A3 (cs) |
| IL (1) | IL125027A0 (cs) |
| NO (1) | NO982816L (cs) |
| NZ (1) | NZ324775A (cs) |
| PT (1) | PT874815E (cs) |
| WO (1) | WO1997023453A1 (cs) |
| ZA (1) | ZA9610874B (cs) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003087048A2 (en) * | 2002-04-11 | 2003-10-23 | Instytut Farmaceutyczny | Preparation of 24 alkyl analogs of cholecalciferol and non-racemic compounds |
| WO2005067673A2 (en) * | 2004-01-06 | 2005-07-28 | The University Of Tennessee Research Foundation | Enzymatic method to produce 7-dehydropregnenolone, vitamin d3-like compounds and derivatives thereof |
| EP1768662A2 (en) | 2004-06-24 | 2007-04-04 | Novartis Vaccines and Diagnostics, Inc. | Small molecule immunopotentiators and assays for their detection |
| WO2006100285A1 (en) * | 2005-03-23 | 2006-09-28 | Bioxell Spa | Use of vitamin d compounds to treat endometriosis |
| TW200714580A (en) * | 2005-10-14 | 2007-04-16 | Formosa Lab Inc | Process for preparing vitamin D analogs |
| WO2010088304A1 (en) | 2009-01-27 | 2010-08-05 | Cytotech Labs, Llc | Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy |
| MX366076B (es) | 2009-08-14 | 2019-06-27 | Berg Llc | Vitamina d3 y analogos de la misma para tratar alopecia. |
| JP5563324B2 (ja) * | 2010-02-03 | 2014-07-30 | フォーモサ・ラボラトリーズ・インコーポレーテッド | マキサカルシトール中間体およびその製造方法 |
| SG10201709894RA (en) | 2013-05-29 | 2018-01-30 | Berg Llc | Preventing or mitigating chemotherapy induced alopecia using vitamin d |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6034543B2 (ja) | 1977-07-01 | 1985-08-09 | 中外製薬株式会社 | ビタミンｄ誘導体 |
| GB9214202D0 (en) | 1992-07-03 | 1992-08-12 | Leo Pharm Prod Ltd | Chemical compounds |
| GB9220439D0 (en) * | 1992-09-28 | 1992-11-11 | Leo Pharm Prod Ltd | Chemical compounds |
| US5397776A (en) * | 1993-08-20 | 1995-03-14 | Wisconsin Alumni Research Foundation | Vitamin D compounds with anti-progesterone activity |
-
1995
- 1995-12-21 GB GBGB9526208.5A patent/GB9526208D0/en active Pending
-
1996
- 1996-12-23 PT PT96943236T patent/PT874815E/pt unknown
- 1996-12-23 ZA ZA9610874A patent/ZA9610874B/xx unknown
- 1996-12-23 CZ CZ19981947A patent/CZ290930B6/cs not_active IP Right Cessation
- 1996-12-23 NZ NZ324775A patent/NZ324775A/xx unknown
- 1996-12-23 DE DE69612568T patent/DE69612568T2/de not_active Expired - Fee Related
- 1996-12-23 US US09/051,483 patent/US6372926B2/en not_active Expired - Fee Related
- 1996-12-23 WO PCT/GB1996/003218 patent/WO1997023453A1/en not_active Application Discontinuation
- 1996-12-23 AT AT96943236T patent/ATE200663T1/de not_active IP Right Cessation
- 1996-12-23 CN CN96180032A patent/CN1086694C/zh not_active Expired - Fee Related
- 1996-12-23 JP JP9523433A patent/JP2000503636A/ja not_active Ceased
- 1996-12-23 IL IL12502796A patent/IL125027A0/xx not_active IP Right Cessation
- 1996-12-23 ES ES96943236T patent/ES2155948T3/es not_active Expired - Lifetime
- 1996-12-23 DK DK96943236T patent/DK0874815T3/da active
- 1996-12-23 EP EP96943236A patent/EP0874815B1/en not_active Expired - Lifetime
- 1996-12-23 AU AU12025/97A patent/AU710680B2/en not_active Ceased
- 1996-12-23 CA CA002241011A patent/CA2241011A1/en not_active Abandoned
- 1996-12-23 KR KR1019980704776A patent/KR19990076664A/ko not_active Ceased
- 1996-12-23 HU HU9903786A patent/HUP9903786A3/hu unknown
-
1998
- 1998-06-18 NO NO982816A patent/NO982816L/no not_active Application Discontinuation
-
2001
- 2001-06-27 GR GR20010400985T patent/GR3036132T3/el not_active IP Right Cessation
-
2002
- 2002-03-07 US US10/091,594 patent/US20020188142A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU710680B2 (en) | 1999-09-30 |
| PT874815E (pt) | 2001-07-31 |
| KR19990076664A (ko) | 1999-10-15 |
| DE69612568D1 (de) | 2001-05-23 |
| EP0874815B1 (en) | 2001-04-18 |
| DK0874815T3 (da) | 2002-03-04 |
| EP0874815A1 (en) | 1998-11-04 |
| NO982816D0 (no) | 1998-06-18 |
| ZA9610874B (en) | 1997-06-18 |
| AU1202597A (en) | 1997-07-17 |
| IL125027A0 (en) | 1999-01-26 |
| CZ194798A3 (cs) | 1998-11-11 |
| GB9526208D0 (en) | 1996-02-21 |
| JP2000503636A (ja) | 2000-03-28 |
| CN1209120A (zh) | 1999-02-24 |
| CN1086694C (zh) | 2002-06-26 |
| GR3036132T3 (en) | 2001-09-28 |
| CA2241011A1 (en) | 1997-07-03 |
| CZ290930B6 (cs) | 2002-11-13 |
| HUP9903786A3 (en) | 2000-09-28 |
| US6372926B2 (en) | 2002-04-16 |
| DE69612568T2 (de) | 2001-09-06 |
| US20020010163A1 (en) | 2002-01-24 |
| HUP9903786A2 (hu) | 2000-03-28 |
| ATE200663T1 (de) | 2001-05-15 |
| ES2155948T3 (es) | 2001-06-01 |
| WO1997023453A1 (en) | 1997-07-03 |
| US20020188142A1 (en) | 2002-12-12 |
| NZ324775A (en) | 1999-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LV12618A (en) | Use of sulphamate derivatives as steroid sulphatase inhibitors | |
| NZ331941A (en) | Pentafluorobenzenesulfonamides and analogs and use in regulation of LDL receptor synthesis | |
| AU1497997A (en) | Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions | |
| CA2223513A1 (en) | Betulinic acid derivatives and uses therefor | |
| NO982816L (no) | 17-sidekjedealkynyl- og 20-oksopregnaderivater av vitamin D, fremgangsmåte ved fremstilling derav og farmasöytiske sammensetninger derav | |
| AU7517400A (en) | N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent | |
| FR2741619A1 (fr) | Nouveaux derives de 2,3,5-trimethyl-4-hydroxy-anilides, leur preparation et leur application en therapeutique | |
| KR910015590A (ko) | 11베타 위치에 아미드 또는 카르바메이트 관능기 함유 탄화 수소 사슬을 가지는 신규한 19-노르 스테로이드, 그의 제조방법 및 중간체, 약물 용도 및 이들을 함유하는 제약 조성물 | |
| FI91070B (fi) | Parannus androsta-1,4-dieeni-3,17-dionin 6-metyleenijohdannaisten synteesissä | |
| DE69518410D1 (de) | 22-thiavitamin-d3-derivate | |
| NO982229L (no) | Svovelholdige di-tert-butylfenol-forbindelser anvendbare som anti-inflammatoriske midler | |
| DE69939106D1 (de) | Verfahren zur Herstellung von ED-71 | |
| EP0605728A4 (en) | Chromone derivative and aldose reductase inhibitor containing the same as active ingredient. | |
| ES2150151T3 (es) | Derivados de 21-(2-oxo-tetrahidrofuran)-tio-pregnano, un procedimiento para su produccion y composiciones farmaceuticas que los contienen. | |
| AR003967A1 (es) | Epimeros de (22r)-n-(1,1,1-trifluoro-2-fenilprop-2-il)-3-oxo-4-aza-5alfa- androst-1-eno-17beta-carboxamida, un proceso para su preparacion y unacomposicion farmaceutica que los comprenden. | |
| HUT67475A (en) | Benzene derivatives and pharmaceutical compositions containing them as active components | |
| MX9604735A (es) | Derivados de la 22-tiavitamina d3. | |
| EE200200302A (et) | Küllastumata 14,15-tsüklopropanoandrostaanid, nende valmistamise meetod ja neid ühendeid sisaldavadfarmatseutilised kompositsioonid | |
| ES2179550T3 (es) | 15-metil-ciclopropanoesteroides y proceso para su preparacion. | |
| NO20014530D0 (no) | Fremgangsmåte for fremstilling av 4, 4-dimetyl-3<beta>- hydroksy-pregna-8, 14-dien-21-karboksylsyreestere ogmellomprodukter ved fremgangsmåten | |
| ECSP961710A (es) | Nuevos derivados de la etanolamina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |